Joshua Breunig

Has grant

Professor

Wake Forest Baptist Medical Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Joshua Breunig is an Assistant Professor at Cedars-Sinai Medical Center in the United States. His research focuses on advanced methodologies in lineage tracing, RNA-protein interactions, and the generation of recipient cell lines for the stable integration of transgenic elements. He has recently published articles that explore innovative techniques for brain tumor research and the development of transgenic models.

Recent Grants

Grant: Open

Enabling in vivo barcoded single-cell multiomics-compatible genome-wide screens in personalized tumor models using defined-copy somatic transgenesis

Open Date: 2024-02-08

Close Date: 2027-01-31

Grant: Close

Interrogating Tumor-Immune-Neuron Cross Talk at Single-Cell Resolution in a Panel of Novel Somatic Transgenic NF1 Tumor Models

Open Date: 2023-09-01

Close Date: 2026-08-31

Grant: Close

Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia

Open Date: 2023-04-15

Close Date: 2024-03-31

Grant: Close

Exploiting Novel Somatic Mosaic Models of Clear Cell Renal Cell Carcinoma as Preclinical Platforms for Combinatorial Testing of Therapeutics

Open Date: 2021-09-01

Close Date: 2024-08-31

Grant: Close

GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models

Open Date: 2019-04-11

Close Date: 2022-03-31

Articles (7)

While many postmitotic cells in the body harbor cilia, certain aggressive cancers such as glioblastoma (GBM) display low frequencies of cells harboring a primary cilium. Ciliated GBM cells that plan to multiply have to disassemble their cilium in order for centrioles to duplicate and re-purpose for mitosis. Little is known about the molecular mechanisms underlying cilia disassembly in GBM, or whether this may represent a driving factor in disease onset, progression, or recurrence. In many cell types, ciliary disassembly is thought to be orchestrated by the aurora kinase A (AURKA) and histone deacetylase 6 (HDAC6) signaling axis. These molecules are often overexpressed in GBM, perhaps owing to the less frequent observation of ciliated GBM cells. Here, we review regulators of the core pathway, and discuss recent studies attempting to inhibit AURKA and HDAC6 in patient and mouse models of GBM and resulting effects on cilia. In the face of potent inhibitors, GBM cells appear to engage pathways independent of the core axis to promote cilia disassembly and/or engage other forms of modified axonemal tubulin to ensure persistence of cilia on GBM cells. GBMs upregulate a host of proteins implicated to drive cilia disassembly. Thus, clarifying these alternate mechanisms may be important as the roles of cilia in tumor formation and propagation, angiogenesis, and treatment resistance are increasingly reported. A deeper understanding of the role of cilia in these hallmarks of glioma may hold clues to the high recurrence rate of GBM.

Year:

2025

Neuronal activity promotes the proliferation of healthy oligodendrocyte precursor cells (OPC) and their malignant counterparts, gliomas. Many gliomas arise from and closely resemble oligodendroglial lineage precursors, including diffuse midline glioma (DMG), a cancer affecting midline structures such as the thalamus, brainstem and spinal cord. In DMG, glutamatergic and GABAergic neuronal activity promotes progression through both paracrine signaling and through bona-fide neuron-to-glioma synapses. However, the putative roles of other neuronal subpopulations - especially neuromodulatory neurons located in the brainstem that project to long-range target sites in midline anatomical locations where DMGs arise - remain largely unexplored. Here, we demonstrate that the activity of cholinergic midbrain neurons modulates both healthy OPC and malignant DMG proliferation in a circuit-specific manner at sites of long-range cholinergic projections. Optogenetic stimulation of the cholinergic pedunculopontine nucleus (PPN) promotes glioma growth in pons, while stimulation of the laterodorsal tegmentum nucleus (LDT) facilitates proliferation in thalamus, consistent with the predominant projection patterns of each cholinergic midbrain nucleus. Reciprocal signaling was evident, as increased activity of cholinergic neurons in the PPN and LDT was observed in pontine DMG-bearing mice. In co-culture, hiPSC-derived cholinergic neurons form neuron-to-glioma networks with DMG cells and robustly promote proliferation. Single-cell RNA sequencing analyses revealed prominent expression of the muscarinic receptor genes CHRM1 and CHRM3 in primary patient DMG samples, particularly enriched in the OPC-like tumor subpopulation. Acetylcholine, the neurotransmitter cholinergic neurons release, exerts a direct effect on DMG tumor cells, promoting increased proliferation and invasion through muscarinic receptors. Pharmacological blockade of M1 and M3 acetylcholine receptors abolished the activity-regulated increase in DMG proliferation in cholinergic neuron-glioma co-culture and in vivo . Taken together, these findings demonstrate that midbrain cholinergic neuron long-range projections to midline structures promote activity-dependent DMG growth through M1 and M3 cholinergic receptors, mirroring a parallel proliferative effect on healthy OPCs. HIGHLIGHTS Activity of midbrain cholinergic neuron long-range projections increases proliferation of both healthy oligodendrocyte precursor cells (OPC) and malignant diffuse midline glioma (DMG) cells. Optogenetic stimulation of cholinergic midbrain nuclei promotes growth in thalamic and pontine glioma in a circuit-dependent manner. Reciprocally, DMG cells increase cholinergic neuronal activity in cholinergic midbrain nuclei. The muscarinic receptors CHRM1 and CHRM3 are identified as therapeutic targets in DMG.

Year:

2024

The steps governing healing with or without fibrosis within the same microenvironment are unclear. After acute kidney injury (AKI), injured proximal tubular epithelial cells activate SOX9 for self-restoration. Using a multimodal approach for a head-to-head comparison of injury-induced SOX9 lineages, we identified a dynamic SOX9 switch in repairing epithelia. Lineages that regenerated epithelia silenced SOX9 and healed without fibrosis (SOX9 on-off ). By contrast, lineages with unrestored apicobasal polarity maintained SOX9 activity in sustained efforts to regenerate, which were identified as a SOX9 on-on Cadherin6 pos cell state. These reprogrammed cells generated substantial single-cell WNT activity to provoke a fibroproliferative response in adjacent fibroblasts, driving AKI to chronic kidney disease. Transplanted human kidneys displayed similar SOX9/CDH6/WNT2B responses. Thus, we have uncovered a sensor of epithelial repair status, the activity of which determines regeneration with or without fibrosis.

Year:

2024

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Collaborators (9)

Sanjeev Kumar

Nephrologist-Scientist

Cedars-Sinai Medical Center

UNITED STATES
View details

Michifumi Yamashita

Associate Professor

Cedars-Sinai Medical Center

UNITED STATES
View details

Subbian Karumanchi

Professor and Medallion Chair in Vascular Biology

Cedars-Sinai Medical Center

UNITED STATES
View details

Hongkui Zeng

Executive Director

Allen Institute for Brain Science

UNITED STATES
View details

Bosiljka Tasic

Director

Allen Institute for Brain Science

UNITED STATES
View details

Michelle Monje

Associate Professor

Stanford University

UNITED STATES
View details

Karl Deisseroth

Stanford University

UNITED STATES
View details

Haruhiko Akiyama

Gifu University Graduate School of Medicine

JAPAN
View details

Maarten Naesens

Professor

Katholieke Universiteit Leuven

BELGIUM
View details